$187 Million is the total value of Invus Financial Advisors, LLC's 8 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Nu Hldgs Ltd | $44,049,476 | +65.8% | 5,582,950 | 0.0% | 23.56% | +36.1% | ||
| CPNG | Sell | Coupang Inccl a | $33,870,335 | -5.8% | 1,946,571 | -13.4% | 18.11% | -22.6% |
| RCUS | Arcus Biosciences Inc | $32,741,284 | +11.3% | 1,612,077 | 0.0% | 17.51% | -8.6% | |
| TBLA | Taboola.com Ltd | $31,005,129 | +14.3% | 9,969,495 | 0.0% | 16.58% | -6.1% | |
| NVCR | Novocure Ltd | $14,561,686 | -31.0% | 350,884 | 0.0% | 7.79% | -43.3% | |
| IONQ Inc | $13,530,000 | +120.0% | 1,000,000 | 0.0% | 7.24% | +80.6% | ||
| Buy | IHS Holding Limited | $9,409,856 | +529.8% | 962,153 | +464.1% | 5.03% | +417.2% | |
| ORIC | Oric Pharmaceuticals Inc | $7,818,782 | +36.1% | 1,007,575 | 0.0% | 4.18% | +11.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Arcus Biosciences Inc | 16 | Q3 2023 | 24.7% |
| Novocure Ltd | 16 | Q3 2023 | 25.4% |
| Oric Pharmaceuticals Inc | 14 | Q3 2023 | 14.3% |
| Oyster Point Pharma Inc | 13 | Q4 2022 | 44.5% |
| Coupang Inc | 11 | Q3 2023 | 51.6% |
| Taboola.com Ltd | 10 | Q3 2023 | 23.7% |
| Unity Biotechnology Inc | 9 | Q4 2021 | 8.0% |
| Yext Inc | 8 | Q3 2021 | 30.3% |
| IONQ Inc | 8 | Q3 2023 | 7.2% |
| Nu Hldgs Ltd | 6 | Q3 2023 | 25.4% |
View Invus Financial Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Invus Financial Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.